(Q44455344)

3 December 2017

title

Long-term outcome of Japanese patients with type 1 autoimmune hepatitis (English)

1 reference

3 December 2017

8

Eiji Tanaka

1 reference

3 December 2017

Kaname Yoshizawa

1

1 reference

3 December 2017

Akihiro Matsumoto

2

1 reference

3 December 2017

Tetsuya Ichijo

3

1 reference

3 December 2017

Takeji Umemura

4

1 reference

3 December 2017

Satoru Joshita

5

1 reference

3 December 2017

Michiharu Komatsu

6

1 reference

3 December 2017

Naoki Tanaka

7

1 reference

3 December 2017

Masao Ota

9

1 reference

3 December 2017

Yoshihiko Katsuyama

10

1 reference

3 December 2017

Kendo Kiyosawa

11

1 reference

3 December 2017

Masanori Abe

12

1 reference

3 December 2017

Morikazu Onji

13

1 reference

3 December 2017

language of work or name

English

0 references

publication date

6 July 2012

1 reference

3 December 2017

1 reference

3 December 2017

volume

56

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

668-676

1 reference

3 December 2017

1 reference

Autoimmune hepatitis, from mechanisms to therapy

21 January 2018

1 reference

Diagnosis and treatment of autoimmune hepatitis

21 January 2018

1 reference

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis

21 January 2018

1 reference

Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience

21 January 2018

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center

21 January 2018

1 reference

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

21 January 2018

1 reference

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

21 January 2018

1 reference

Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis

21 January 2018

1 reference

Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients

21 January 2018

1 reference

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

21 January 2018

1 reference

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

21 January 2018

1 reference

Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Genetic background of autoimmune hepatitis in Japan.

21 January 2018

1 reference

Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.

21 January 2018

1 reference

Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.

21 January 2018

1 reference

Large Intrahepatic Cholangiocarcinoma with Tumor Infiltrative Lymphocytes and Autoimmune Hepatitis-Like Features

21 January 2018

1 reference

Use of endoscopic ultrasound for diagnosis of cholangiocarcinoma in auto-immune hepatitis

21 January 2018

1 reference

Autoimmune hepatitis in Italy: the Bologna experience

21 January 2018

1 reference

Autoimmune hepatitis: the dilemma of rare diseases

21 January 2018

1 reference

Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis

21 January 2018

1 reference

Controlled trial of prednisone and azathioprine in active chronic hepatitis

21 January 2018

1 reference

7 January 2021

Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis

1 reference

7 January 2021

Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis

1 reference

7 January 2021

Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

7 January 2021

Consequences of treatment withdrawal in type 1 autoimmune hepatitis

1 reference

7 January 2021

Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis

1 reference

7 January 2021

HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients

1 reference

7 January 2021

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

7 January 2021

A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1

1 reference

7 January 2021

Cholangiocarcinoma: expanding the spectrum of risk factors

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25658

1 reference

3 December 2017

1 reference